Back

Hengrui Medicine secures approvals for 10 drug trials in two days

Verifying
  • Hengrui Medicine secured clinical trial approvals for 10 drugs from China’s NMPA.
  • Ten drugs received approval notifications within two days.
  • Hengrui’s approved programs cover oncology, metabolic diseases and chronic kidney disease.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.